Docoh
Loading...

Brian Goff

Brian Goff is EVP & Chief Commercial Officer of Alexion Pharmaceuticals, Inc.

Person profile

Roles
Alexion Pharmaceuticals EVP & Chief Commercial Officer
Address
New Haven, Connecticut
Employees
SEC CIK

Calendar

25 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
21 Jul 21 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Sale back to company Dispose D No No 0 150,832 0 0
21 Jul 21 ALXN Alexion Pharmaceuticals Option to Purchase Common Stock Common Stock, par value $.0001 per share Sale back to company Dispose D No No 100.14 21,750 2.18M 0
14 Jul 21 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Grant Acquire A No No 0 29,501 0 150,832
14 Jul 21 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Grant Acquire A No No 0 30,643 0 121,331
8 Jun 21 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Payment of exercise Dispose F No No 177 1,086 192.22K 90,688
28 Feb 21 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Grant Acquire A No No 0 24,473 0 91,774
16 Dec 20 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Payment of exercise Dispose F No No 157.96 3,261 515.11K 67,301
16 Dec 20 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Payment of exercise Dispose F No No 157.96 18,134 2.86M 70,562
16 Dec 20 ALXN Alexion Pharmaceuticals Common Stock, par value $.0001 per share Grant Acquire A No No 0 40,677 0 88,696

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings